Savant Capital LLC Raises Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Savant Capital LLC boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,080 shares of the biotechnology company’s stock after buying an additional 58 shares during the period. Savant Capital LLC’s holdings in Axon Enterprise were worth $642,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of AXON. Prestige Wealth Management Group LLC lifted its holdings in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares during the period. New Wave Wealth Advisors LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $40,000. Brooklyn Investment Group bought a new position in shares of Axon Enterprise during the third quarter valued at approximately $41,000. Y.D. More Investments Ltd bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $45,000. Finally, Planning Capital Management Corp increased its stake in shares of Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 2,304 shares of the business’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the sale, the insider now owns 128,542 shares of the company’s stock, valued at $84,168,016.18. The trade was a 1.76 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, President Joshua Isner sold 1,291 shares of the business’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the sale, the president now directly owns 181,892 shares of the company’s stock, valued at approximately $116,852,877.56. The trade was a 0.70 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,711 shares of company stock worth $5,631,561. Insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON opened at $683.41 on Friday. The firm has a market cap of $52.11 billion, a PE ratio of 176.59, a P/E/G ratio of 6.79 and a beta of 1.05. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a fifty day simple moving average of $623.22 and a two-hundred day simple moving average of $507.71. Axon Enterprise, Inc. has a 1-year low of $260.27 and a 1-year high of $698.67.

Analysts Set New Price Targets

A number of brokerages have weighed in on AXON. Northland Securities raised their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. JMP Securities raised their price target on shares of Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 4th. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $542.15.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.